Cite

HARVARD Citation

    Grimaldi, A. et al. (2015). Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record